£2m management buy out at Manchester life-sciences firm
Private equity investor Foresight has backed a £2m management buy-out at the contract research business Epistem.
Manchester based Epistem is a life sciences services company which focuses on providing research services for both pre-clinical and clinical development across several specialist therapeutic areas, including oncology and inflammatory diseases.
Clients include several global pharmaceutical businesses, US Biodefence programmes and niche biotechnology companies.
Foresight’s investment, which includes an injection o... For the full story register now for free or login below...